Avraham Ishay

Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial

Stefano Del Prato, Steven E. Kahn, Imre Pávó et al. · The Lancet · 2021 · 586 citations

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Lamotrigine reduces painful diabetic neuropathy

Elon Eisenberg, Yoav Lurie, Clara Braker et al. · Neurology · 2001 · 299 citations

Lamotrigine in the treatment of painful diabetic neuropathy

Elon Eisenberg, N. Alon, Avraham Ishay et al. · European Journal of Neurology · 1998 · 73 citations

Pain Therapy, Pain Medicine, Neuropathic Pain +20

Effects of Successful Parathyroidectomy on Metabolic Cardiovascular Risk Factors In Patients With Severe Primary Hyperparathyroidism

Avraham Ishay, Paula Herer, Rafael Luboshitzky · Endocrine Practice · 2011 · 52 citations

Hypertension, Urology, Parathyroid Hormone +6

Increased 6-sulfatoxymelatonin excretion in women with polycystic ovary syndrome

Rafael Luboshitzky, Ghali Qupti, Avraham Ishay et al. · Fertility and Sterility · 2001 · 51 citations

Female Infertility, Reproductive Health, Gynecology +7